Hyperglycemia News and Research

RSS
Hyperglycemia occurs when you have a higher than usual level of glucose in your blood. This can happen shortly after you have eaten a big meal and is not a problem if your glucose level returns to normal. Cells remove glucose from the blood in response toinsulin. If your pancreas doesn't make enough insulin, glucose can't enter the cells and remains in the blood. Blood glucose levels can also get too high if cells areunable to respond to insulin properly (insulinresistance). Without glucose, your cells are unable to make energy and can't function properly.
New review of infants with congenital hyperinsulinism shows surgery benefits

New review of infants with congenital hyperinsulinism shows surgery benefits

MU researchers use new techniques to fight against diabetic retinopathy

MU researchers use new techniques to fight against diabetic retinopathy

Tattoo sensor: A needleless glucose monitor for diabetes patients

Tattoo sensor: A needleless glucose monitor for diabetes patients

FDA permits marketing of Dexcom G6 integrated continuous glucose monitoring system

FDA permits marketing of Dexcom G6 integrated continuous glucose monitoring system

New study identifies the body's 'glucostat'

New study identifies the body's 'glucostat'

Hypoglycemia poses unaddressed threat to type 2 diabetes patients

Hypoglycemia poses unaddressed threat to type 2 diabetes patients

Women with Type 1 diabetes come across unique challenges

Women with Type 1 diabetes come across unique challenges

Research project succeeds in palliating kidney disease caused by diabetes in mice

Research project succeeds in palliating kidney disease caused by diabetes in mice

Researchers uncover novel therapeutic target for type 2 diabetes

Researchers uncover novel therapeutic target for type 2 diabetes

FDA approves new radioactive drug for treatment of rare digestive tract cancers

FDA approves new radioactive drug for treatment of rare digestive tract cancers

Researchers identify potential enzyme as therapeutic target for type 2 diabetes

Researchers identify potential enzyme as therapeutic target for type 2 diabetes

Research opens door to development of new treatment for type 2 diabetes

Research opens door to development of new treatment for type 2 diabetes

New research finds out how cinnamon may help fight against obesity

New research finds out how cinnamon may help fight against obesity

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Key features that distinguish Brittle Type 1 Diabetes from stable T1D

Key features that distinguish Brittle Type 1 Diabetes from stable T1D

Hospitals need to improve emergency care practices for treating older cancer patients, study reveals

Hospitals need to improve emergency care practices for treating older cancer patients, study reveals

New study describes how gene-environment interaction leads to congenital heart defects

New study describes how gene-environment interaction leads to congenital heart defects

Study identifies new biomarker for depression in diabetes

Study identifies new biomarker for depression in diabetes

Crown Bioscience announces availability of new translational models for obesity and diabetes in Europe

Crown Bioscience announces availability of new translational models for obesity and diabetes in Europe

FDA approves FreeStyle Libre Flash Glucose Monitoring System for adult patients with diabetes

FDA approves FreeStyle Libre Flash Glucose Monitoring System for adult patients with diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.